DrFadil Bidmos
Proleptic Associate Professor in Bacterial Vacc
Department of Infectious Disease - Faculty of Medicine
Orcid identifier0000-0003-2843-409X (opens in a new tab)
- Proleptic Associate Professor in Bacterial VaccDepartment of Infectious Disease - Faculty of Medicine
- 020 7594 6651 (Work)
- Rm 150, Sir Alexander Fleming Building, Department of Infectious Disease, Imperial College London, South Kensington Campus, London, SW7 2AZ, United Kingdom
BIO
Fadil Bidmos obtained a BSc degree in Cell Biology and Genetics from the University of Lagos, Nigeria before moving to the University of Leicester, UK where he successfully completed MSc and PhD degrees in Molecular Genetics.
His research programme, generously supported by prestigious UK Medical Research Council fellowships (Career Development Award, 2019 - 2024; and Senior Non-Clinical Fellowship, 2024 - 2029) and US National Institute of Health innovation grants, focusses on designing and developing next-generation vaccines that will combat disease caused by the most prevalent bacterial pathogens of global economic importance. With the chief causes of bacterial meningitis, Neisseria meningitidis and Streptococcus pneumoniae, as exemplar, his lab is employing the ingenious integration of cutting-edge methodologies such as Reverse Vaccinology 2.0 and protein-glycan coupling technology, alongside groundbreaking efforts in synthetic cell engineering, to the development of a highly efficacious and combination vaccine. Additionally, his lab takes on the challenge of antimicrobial resistance, focusing on vaccines against N. gonorrhoeae as a prime example, and is contributing to the One Health agenda via the generation of a toolbox (optimised protocols and pipelines) that will be translatable, following minor modifications, to animal pathogens. Indeed, the prevention of, and/or rapid vaccine development response to, future pandemics and bioterrorism threats of zoonotic bacterial aetiology will be an added benefit that his research offers and is actively pursuing.
Throughout his career, he has demonstrated a strong commitment to education, supporting both undergraduate and postgraduate students at Imperial College London and other prestigious institutions worldwide. In recognition of his exceptional teaching standards, he was awarded Fellowship of the UK Higher Education Academy (FHEA) in 2016. Additionally, his outstanding management and leadership skills were acknowledged with the Chartered Fellowship (FCMI CMgr) of the UK Chartered Management Institute in 2023. These accolades underscore his dedication to fostering learning and development while exemplifying excellence in both academia and leadership
His research programme, generously supported by prestigious UK Medical Research Council fellowships (Career Development Award, 2019 - 2024; and Senior Non-Clinical Fellowship, 2024 - 2029) and US National Institute of Health innovation grants, focusses on designing and developing next-generation vaccines that will combat disease caused by the most prevalent bacterial pathogens of global economic importance. With the chief causes of bacterial meningitis, Neisseria meningitidis and Streptococcus pneumoniae, as exemplar, his lab is employing the ingenious integration of cutting-edge methodologies such as Reverse Vaccinology 2.0 and protein-glycan coupling technology, alongside groundbreaking efforts in synthetic cell engineering, to the development of a highly efficacious and combination vaccine. Additionally, his lab takes on the challenge of antimicrobial resistance, focusing on vaccines against N. gonorrhoeae as a prime example, and is contributing to the One Health agenda via the generation of a toolbox (optimised protocols and pipelines) that will be translatable, following minor modifications, to animal pathogens. Indeed, the prevention of, and/or rapid vaccine development response to, future pandemics and bioterrorism threats of zoonotic bacterial aetiology will be an added benefit that his research offers and is actively pursuing.
Throughout his career, he has demonstrated a strong commitment to education, supporting both undergraduate and postgraduate students at Imperial College London and other prestigious institutions worldwide. In recognition of his exceptional teaching standards, he was awarded Fellowship of the UK Higher Education Academy (FHEA) in 2016. Additionally, his outstanding management and leadership skills were acknowledged with the Chartered Fellowship (FCMI CMgr) of the UK Chartered Management Institute in 2023. These accolades underscore his dedication to fostering learning and development while exemplifying excellence in both academia and leadership
ACADEMIC POSITIONS
- Proleptic Asscoiate Professor in Bacterial VaccinologyImperial College London, Infectious Disease, London, United Kingdom2 Sep 2024 - present
DEGREES
- PhDUniversity of Leicester, LEICESTER, United Kingdom4 Jan 2010 - 1 Nov 2013
- MSc Molecular GeneticsUniversity of Leicester, United Kingdom17 Sep 2007 - 2 Sep 2008
- BSc Cell Biology and GeneticsUniversity of Lagos, Nigeria9 Oct 2000 - 31 Mar 2005
CERTIFICATIONS
- FellowHigher Education Academy, United Kingdom19 Jul 2016 - present
- Associate FellowHigher Educatio Academy, United Kingdom17 Jul 2015 - 18 Jul 2016
POSTGRADUATE TRAINING
- Level 7 Strategic Management and Leadership PracticeImperial College Business School and Corndel, United Kingdom21 Jun 2022 - 31 Oct 2023Other
LANGUAGES
- EnglishCan read, write, speak, understand and peer review
- YorubaCan read, write, speak, understand and peer review
- ArabicCan read, write, speak and understand
FACULTY
- Faculty of Medicine
POSITION NAME
- Proleptic Associate Professor in Bacterial Vacc